November 2, 2026 · JACC. Cardiovascular interventions · DOI: 10.1016/j.jcin.2026.10.023

1-Year Safety and Effectiveness of a Next-Generation Dual-Seal Left Atrial Appendage Occluder.

Listen to this summary

The VERITAS study asked whether a next-generation dual-seal left atrial appendage occluder could provide safe and effective stroke prevention through 1 year in patients with atrial fibrillation who seek an alternative to long-term oral anticoagulation. In this single-arm, prospective, global trial, complete LAA closure (0 mm peridevice leak) was seen in 91.1% of patients by TEE or CT (96.3% by TEE alone), with a cumulative device-related thrombus rate of 3.3% and no device embolizations. One-year outcomes included all-cause mortality of 3.9%, major bleeding of 6.6%, and ischemic stroke or systemic embolism of 1.8%, supporting the device's 1-year safety and effectiveness.

Dhanunjaya Lakkireddy, Akash Makkar, Mohamad Alkhouli, Xavier Freixa, George Manoukian, Himanshu Agarwal, Hussam Abuissa, Khaled Awad, Frank Cuoco, Mustafa Dohadwala, Christopher R Ellis, Dipak Shah, Ole De Backer, Larry Chinitz, Jens Erik Nielsen-Kudsk, Rodney P Horton, Boris Schmidt, Andrea Natale, Vivek Y Reddy, Sajjad A Sabir, Courtney Weiler, Devi Nair

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play